Gary W. Pace, Director at Cardiff Oncology, Inc. (CRDF), bought 895,522 shares at $1.34 ($1.2M) on 2020-05-11, disclosed to the SEC on 2020-05-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.34 | 447,761 | $600K | 50.0% |
| 2 | $1.34 | 447,761 | $600K | 50.0% |
| Total | $1.34 avg | 895,522 | $1.2M | 100% |
| Filing → |
| CRDF | BUY | 2025-07-31 | $711K | — | Filing → |
| CRDF | BUY | 2024-12-12 | $940K | — | Filing → |
| PCRX | SELL | 2024-03-08 | $4.5M | — | Filing → |